Search for: "Merck and Co "
Results 861 - 880
of 1,266
Sort by Relevance
|
Sort by Date
15 May 2009, 8:22 am
Merck & Co., Inc., 929 A.2d 1076, 1085-86 (N.J. 2007), the court both took the NJ consumer fraud act off the table by broadly rejecting fraud-on-the-market type theories of proving causation. [read post]
1 May 2009, 8:25 am
SEC Investigating Schering-Plough Trades: The SEC is investigating trading of Schering-Plough shares ahead of the announcement of its merger with Merck & Co., people familiar with the matter said. [read post]
20 Apr 2009, 2:24 pm
Docket: 08-905 Title: Merck & Co., Inc., et al., Petitioners v. [read post]
16 Apr 2009, 7:27 am
" Notably, "Eli Lilly and Co., Pfizer Inc., Novartis Pharmaceuticals Corp., Merck & Co. and Forest Pharmaceuticals Inc. were the biggest spenders. [read post]
15 Apr 2009, 4:44 am
Co. v. [read post]
13 Apr 2009, 5:00 am
Another example is Merck’s authorized generic deal with Dr. [read post]
6 Apr 2009, 8:20 am
" Among those companies ordered "to stop using the ads" were "Merck & Co., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
26 Mar 2009, 6:54 am
Fosamax is manufactured by Merck & Co., a pharmaceutical company that courts are currently holding legally responsible for the companies arthritis drug Vioxx because of the drugs correlation to patient heart attacks. [read post]
24 Mar 2009, 2:49 pm
The AP reports, "Merck & Co. said Monday it received a letter from federal prosecutors notifying the company it is 'a target' of a grand jury investigation involving the painkiller Vioxx [rofecoxib], which Merck pulled from the market in 2004. [read post]
23 Mar 2009, 2:24 am
"
Judge Won't Certify Class Action by Vioxx Users Seeking Reimbursement " An Atlantic County judge has denied a request to certify a class action against Merck & Co. on behalf of consumers for their out-of-pocket expenses for the painkiller Vioxx, which was withdrawn from the market in 2004 after a medical study linked it to heart disease. [read post]
20 Mar 2009, 3:54 am
Merck & Co., Inc. [read post]
20 Mar 2009, 2:05 am
Upjohn Co., 465 So.2d 42, 45 (La. [read post]
20 Mar 2009, 1:19 am
Judge Won't Certify Class Action by Vioxx Users
New Jersey Law Journal
A New Jersey judge on Tuesday denied a request to certify a class action against Merck & Co. on behalf of consumers for their out-of-pocket expenses for the painkiller Vioxx, withdrawn from the market in 2004 after a medical study linked it to heart disease. [read post]
19 Mar 2009, 2:18 pm
Introduction On March 9, 2009 Merck Co., Inc. [read post]
16 Mar 2009, 11:20 am
According to this report, the professional journal Current Medical Research and Opinion, recently published the findings of an analysis that used an insurance company database to show that neither Byetta nor Januvia -- a diabetes drug from Merck & Co. -- increased the risk for pancreatitis, which is an inflammation of the pancreas. [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell limits on… [read post]
12 Mar 2009, 1:40 pm
Jeffrey Kroin, who co-wrote four papers with Dr. [read post]
9 Mar 2009, 9:52 pm
On the heels of Pfizer's $68 billion acquisition of Wyeth (see "Pfizer Expected to Announce Wyeth Acquisition on Monday") in January, Merck & Co., Inc. and Schering-Plough Corp. announced today that their Boards of Directors had unanimously approved a definitive merger agreement under which Schering-Plough shareholders will receive 0.5767 shares and $10.50 in cash for each share of Schering-Plough stock and each share of Merck stock will become a… [read post]
8 Mar 2009, 10:48 pm
MarketWatch reports: Pharmaceutical giant Merck & Co., Inc on March 9 said it will buy rival Schering-Plough for $41.1 billion in cash and shares to expand its presence in emerging markets and bolster its pipeline of potential new medicines.The two companies, which announced significant job cuts last fall, already are partners on the cholesterol drugs Zetia and Vytorin. [read post]
3 Mar 2009, 6:37 am
Merck & Co., 948 A.2d 587, 590 (N.J. 2008), held that CFA was subsumed by the state's product liability act and thus did not provide a separate cause of action.Anyway, two weeks later, we've now discovered (we get sent good news, but not bad news, it seems), the New Jersey Supreme Court held that, generally, a request for a refund is not a prerequisite to bring suit under the CFA:In theory, there may be circumstances in which requiring a pre-suit demand for relief… [read post]
